NEW YORK, April 11, 2016 -- FolioDynamix, a leading provider of wealth management technology and advisory services, today announced that it will host a webinar titled “Success in the Wake of the DOL Fiduciary Rule” on Tuesday, April 26 at 4:00 p.m. ET. The complimentary webinar will present experts on the just-released regulation to share insights and guidance around how firms can not only survive but thrive within the industry’s new culture of compliance.
“The DOL Fiduciary Rule change finds many financial services firms working to put steps and solutions in place to help advisors affected by the expansion of the ‘best interest standards’ to individual retirement accounts and 401(k) rollovers,” says Steve Dunlap, president of FolioDynamix. “There was a great deal of discussion in advance of the regulation with firms and advisors unclear as to what would pass; now that the rule has been finalized, our goal is to help wealth management firms navigate this new environment while minimizing the cost increases resulting from compliance to the rule.”
FolioDynamix will host this webinar with experts including Dunlap and President of FDx Advisors, Shari Hensrud, as well as Cary Kvitka, Stephen Galletto and Max Schatzow, authorities on the DOL rule from Stark & Stark’s Securities Group. The panel will discuss the impact of the new rule on the industry at large, how to mitigate compliance risks following the roll out and even given wide-ranging concerns about the threats to the industry at large, where opportunities might lie for financial services firms. Though the final regulation did offer longer timeframes for compliance, as well as less draconian approach to the “Best Interest Client Exemption,” the focus on the fiduciary standard remains. The panelists will discuss how firms should prepare now to succeed going forward in an environment where the shift to advisory business is becoming almost inevitable.
In addition to this webcast, FolioDynamix is offering additional tools to support firms and advisors in this effort. In partnership with industry research group Beacon Strategies, LLC, FolioDynamix has created a high-level whitepaper on the DOL fiduciary rule to help firms and advisors drill down to the actual impact of the regulation. FolioDynamix is also offering a complimentary “DOL Risk Exposure Assessment,” during which an FDX Advisors analyst will spend time with a firm to run through their retirement business and offer suggestions to allow firms to meet the regulations by the deadline.
Registration for “Success in the Wake of the DOL Fiduciary Rule” is free; visit http://www.foliodynamix.com/dol-fiduciary/ to download webcast information.
About FolioDynamix
FolioDynamix offers the most comprehensive web-based wealth management technology platform for managing the full advisory lifecycle – proposal generation, research, model management, portfolio accounting, trade order management, reporting, and performance analytics. The FolioDynamix platform is truly unified to eliminate silos and empower advisors with a single platform to manage all customer accounts. FolioDynamix provides registered investment advisors, banks, broker dealers, custodians and wealth service providers with leading-edge technology to attract and retain advisors, accelerate client acquisition and gain visibility across all assets under management. The results are improved efficiency, stronger compliance, enhanced client service and faster growth. FolioDynamix is an Actua company (Nasdaq:ACTA). Visit www.foliodynamix.com. Follow us on Twitter @foliodx.
Press Contact: Meghan McCartan +1 201-605-1926 [email protected]


Niigata Set to Approve Restart of Japan’s Largest Nuclear Power Plant in Major Energy Shift
Novo Nordisk Stock Surges After FDA Approves Wegovy Pill for Weight Loss
Nvidia to Acquire Groq in $20 Billion Deal to Boost AI Chip Dominance
FDA Approves Mitapivat for Anemia in Thalassemia Patients
Mexico Antitrust Review of Viva Aerobus–Volaris Deal Signals Growth for Airline Sector
Saks Global Weighs Chapter 11 Bankruptcy Amid Debt Pressures and Luxury Retail Slowdown
Uber and Baidu Partner to Test Robotaxis in the UK, Marking a New Milestone for Autonomous Ride-Hailing
AstraZeneca’s LATIFY Phase III Trial of Ceralasertib Misses Primary Endpoint in Lung Cancer Study
JPMorgan’s Top Large-Cap Pharma Stocks to Watch in 2026
California Regulator Probes Waymo Robotaxi Stalls During San Francisco Power Outage
BP Nears $10 Billion Castrol Stake Sale to Stonepeak
DOJ Reaches Settlement With Blackstone’s LivCor Over Alleged Rent Price-Fixing
Waymo Plans Safety and Emergency Response Upgrades After San Francisco Robotaxi Disruptions
Italy Fines Apple €98.6 Million Over App Store Dominance
Sanofi to Acquire Dynavax in $2.2 Billion Deal to Strengthen Vaccines Portfolio
Warner Bros Discovery Weighs Amended Paramount Skydance Bid as Netflix Takeover Battle Intensifies 



